Lodestar Private Asset Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$893K Buy
3,655
+7
+0.2% +$1.63K 0.09% 109
2025
Q4
$755K Sell
3,648
-249
-6% -$49.2K 0.08% 123
2025
Q3
$723K Buy
3,897
+729
+23% +$125K 0.08% 123
2025
Q2
$484K Sell
3,168
-269
-8% -$41.3K 0.06% 144
2025
Q1
$570K Sell
3,437
-325
-9% -$50.9K 0.07% 127
2024
Q4
$544K Sell
3,762
-116
-3% -$18K 0.07% 132
2024
Q3
$628K Sell
3,878
-175
-4% -$27.9K 0.08% 125
2024
Q2
$592K Sell
4,053
-86
-2% -$12.8K 0.08% 125
2024
Q1
$655K Sell
4,139
-277
-6% -$44.1K 0.09% 121
2023
Q4
$692K Sell
4,416
-738
-14% -$113K 0.11% 114
2023
Q3
$803K Sell
5,154
-739
-13% -$122K 0.14% 99
2023
Q2
$975K Sell
5,893
-33
-0.6% -$5.33K 0.16% 89
2023
Q1
$918K Buy
5,926
+582
+11% +$94K 0.16% 94
2022
Q4
$944K Buy
+5,344
New +$923K 0.18% 89

Other funds holding JNJ

Lodestar Private Asset Management's JNJ Position: Q1 2026 in Review

Lodestar Private Asset Management increased its Johnson & Johnson (JNJ) stake by 0.19% in Q1 2026, buying an estimated $1.63K and bringing the position to 3,655 shares worth $893K. The position accounts for 0.09% of the portfolio, ranked #109.

Lodestar Private Asset Management first reported a position in JNJ in Q4 2022 and has held it in 14 quarters since. The position peaked at $975K in Q2 2023. 4,613 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Lodestar Private Asset Management held 3,655 shares of Johnson & Johnson worth $893K as of Q1 2026.
  • Lodestar Private Asset Management bought 7 Johnson & Johnson shares in Q1 2026, an estimated $1.63K.
  • Johnson & Johnson made up 0.09% of Lodestar Private Asset Management's portfolio in Q1 2026, its #109 holding.
  • Lodestar Private Asset Management first reported a position in Johnson & Johnson in Q4 2022 and has held it in 14 quarters since.
  • Lodestar Private Asset Management's Johnson & Johnson position peaked at $975K in Q2 2023.
  • 4,613 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Lodestar Private Asset Management's 13F filing for Q1 2026, filed 27 Apr 2026.